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Abstract 35 
Purpose:   To identify if there is an association between fetal haemoglobin (HbF) concentration and 36 
retinopathy of prematurity (ROP) in very preterm infants. 37 
Methods:   Prospective cohort study. Infants born <32 weeks’ gestational age or <1501g in two tertiary 38 
neonatal units between January 2012 and May 2013 (n=42) were enrolled. Fetal haemoglobin (HbF) 39 
and adult haemoglobin (HbA) concentrations were measured using High Pressure Liquid 40 
Chromatography from blood samples sent as part of routine neonatal care once routinely requested 41 
laboratory tests had been performed. Clinical data were obtained from case notes. We calculated 42 
Odds Ratios (95% CIs) to quantify the relationship between initial and mean %HbF with ROP severity 43 
(none, Stages 1,2,3). 44 
Results:   42 infants were recruited: mean gestation 28.0w (SD 1.91); mean birthweight 1042g (SD 45 
264). 6 infants died before ROP screening; 14/36 developed ROP (39%) and 22/36 (61%) did not. 46 
Infants who developed ROP had similar initial %HbF (83.3%  vs. 92.3%, p=0.06) but significantly lower 47 
mean %HbF (61.75% vs. 91.9%, p=0.0001) during their inpatient stay than those who did not develop 48 
ROP. In Ordinal Logistic regression models adjusted for birthweight, gestation and transfusion volume, 49 
mean postnatal %HbF was negatively associated with ROP severity: adjusted OR 0.94 (0.90-0.99) 50 
whilst initial  %HbF at birth  was not: adjusted OR 1.05 (0.97 – 1.16). 51 
Conclusion: Replacing HbF by HbA during transfusion may promote ROP development by rapidly 52 
increasing oxygen availability to the retina. Conversely, maintaining a higher %HbF may be a protective 53 
factor against ROP. 54 
Word limit=  239/250 55 
Keywords: Retinopathy, prematurity, transfusion, fetal haemoglobin 56 
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Introduction 59 
Studies in preterm neonates have highlighted that a balance must be found between the toxic effects 60 
of high oxygen saturations and the increased morbidity and mortality associated with targeting lower 61 
saturations.1-4 Birth weight and gestation have also been shown to be consistently independently 62 
associated with ROP development. A number of other factors appear to have an association with ROP, 63 
including genetics, poor nutrition and poor weight gain, sepsis and necrotising enterocolitis.5- 7 Various 64 
studies have identified an association between ROP and blood transfusion.8-10 65 
Neonates have a predominance of fetal haemoglobin (HbF) at birth. Approximately 85% of total 66 
haemoglobin is HbF in infants born at 35 weeks' gestation which gradually declines until it has 67 
disappeared by the age of 1-2 years.11, 12 HbF has a greater affinity for oxygen compared to HbA, 68 
shifting the haemoglobin-oxygen dissociation curve to the left, causing preferential fetal oxygen 69 
binding in utero. However, HbF preponderance postnatally in very preterm infants leads to greater 70 
difficulty unloading oxygen to the tissues. This is partly offset by a steeper oxygen-haemoglobin 71 
dissociation curve than that for HbA, but exacerbated as the levels of 2,3-diphosphoglycerate (a 72 
product of glycolysis that promotes oxygen release from oxy-haemoglobin) are low in preterm 73 
neonates.13 74 
Anaemia of prematurity, in part thought to be related to reduced red cell life span and low 75 
erythropoietin levels, is exacerbated by clinical blood sampling, leading to the need for blood 76 
transfusion in many very preterm infants.14 De Halleux V et al, 2002,15 demonstrated clinically that the 77 
oxygen-haemoglobin dissociation curve is shifted to the right in preterm infants after blood 78 
transfusion. We hypothesised that as the HbF:HbA ratio decreases with blood transfusion, more 79 
oxygen is made available to the developing retina for any given arterial partial pressure of oxygen 80 
(PaO2), possibly contributing to ROP development by increasing the oxygen availability in the 81 
developing retina and reducing angiogenic drive. We aimed to explore whether there might be an 82 
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association between either initial %HbF (on admission after birth) and/or the mean inpatient HbF% 83 
(during their hospital admission), with the development of ROP in very preterm infants. 84 
 85 
Methods 86 
Study design 87 
We conducted a prospective cohort study across two tertiary neonatal intensive care units in Bristol, 88 
UK (St. Michael's and Southmead Hospital). All inborn infants and those retrieved from neighbouring 89 
hospitals within 24 hours of birth born <32 weeks' gestation or <1501 grams were eligible for inclusion. 90 
Parents were counselled as to the nature of the study and provided with an information leaflet.  With 91 
informed parental consent all routine EDTA samples taken during the baby’s admission were analysed 92 
for HbF%, HbA% and HbF:A ratio. No additional blood samples were taken for the purposes of the 93 
study. Analysis of HbF and HbA were performed at a single site (Southmead Hospital) using high 94 
performance liquid chromatography (BioRad Variant II HPLC analyser; daily calibration; 5 μl blood 95 
sample volume). Recruited patients received routine neonatal care and the existing local protocol was 96 
followed for blood transfusion thresholds. Infants received on site retinopathy screening by a single 97 
consultant ophthalmologist according to national guidelines.16  98 
Data collection 99 
Patient case notes were reviewed after discharge from the neonatal unit (discharge home or transfer 100 
to other neonatal unit) and demographic and clinical information were extracted in addition to 101 
reviewing computerised laboratory reporting systems as follows: gestational age, birth weight, sex, 102 
ethnicity, multiple pregnancy, days on respiratory support, days in supplementary oxygen, duration 103 
of stay, corrected gestational age at discharge. Haematological data was extracted as follows: Hb, 104 
%HbF, %HbA, HbF:HbA ratio, and blood transfusions (date, time and volume as ml/kg). Episodes of 105 
infection were identified as definite (blood culture positive, CRP rise >10 and ≥5 days antibiotics), 106 
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probable (CRP rise >10 or positive blood culture, and ≥5 days antibiotics), or not present. ROP 107 
screening data was recorded from patient notes for the duration of their ROP screening, according to 108 
established nomenclature.17 If there was no ROP at any time, the ROP outcome was recorded as stage 109 
0, whilst for any infant that did develop ROP, the worst stage in the worst eye was used as their 110 
outcome. The presence or absence of “Plus” (or “Pre-plus”) disease was also noted. For those infants 111 
discharged to other neonatal units before retinopathy screening had been completed, data was 112 
extracted from BadgerNet, an electronic patient data management system. 113 
Data analysis 114 
Initial %HbF (on admission after birth) and demographics on the cohort were extracted from the notes 115 
along with the results from their ROP screening examinations. Mean %HbF (during in-patient stay) 116 
was derived using time-weighted averaging (multiplying each %HbF value by the length of time 117 
between samples, and then averaging the results for the whole period of an infant’s in-patient stay). 118 
Initial univariate comparisons were carried out between those infants who developed any ROP versus 119 
those who did not, with respect to their HbF values. %HbF from each full blood count was plotted 120 
against corrected gestational age.  An ordered logistic regression model was used to calculate Odds 121 
Ratios (ORs) and 95% Confidence Intervals to estimate the association between the value of the %HbF 122 
(either initial, or mean of inpatient stay) with the most severe stage of ROP recorded for each baby (0, 123 
1, 2, 3). Corresponding adjusted ORs were derived after including gestation, birthweight, and total 124 
volume of red blood cell transfusions in the logistic regression model. 125 
Analysis was performed using STATA 10 (Stata Corp) and results are presented as number (%), mean 126 
(standard deviation), median (inter-quartile range) or OR (95% confidence interval) as appropriate. 127 
Ethical approval was obtained from The NRES Committee North East Newcastle and North Tyne 2. 128 
 129 
Results 130 
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42 infants were recruited between January 2012 and November 2013. No infants were excluded from 131 
the study. All parents approached for recruitment during the study agreed to be enrolled except the 132 
parents of one set of twins. Demographic data for the cohort, split by ROP status are displayed in Table 133 
1. 134 
Table 1 135 
37 neonates were inborn and 5 infants were outborn. All outborn infants were born in a local district 136 
general hospital, retrieved by the tertiary neonatal team and arrived in the tertiary neonatal unit 137 
before 10 hours of age. 6 infants died before ROP screening (3 male, 3 female) of which 4 were inborn 138 
and 2 were outborn. Infants who developed ROP were more likely than infants who did not develop 139 
ROP to be from multiple births (p=0.027), more preterm (p<0.001), of lower birthweight (p=0.007), to 140 
have had more transfusions (p<0.001), larger volumes infused (p<0.001), and to have spent longer on 141 
ventilators (p<0.001) and Continuous Positive Airway Pressure (CPAP) (p=0.028). 142 
24 infants received a transfusion of red blood cells (RBC) during their admission (57%). Of the 36 143 
infants who survived to ROP screening all survived to discharge from the tertiary unit. 22 of these 144 
infants did not develop ROP (52% of the initial cohort). 14 infants developed ROP (33% of the initial 145 
cohort): stage 1 (n=5), stage 2 (n=4), stage 3 (n=5, 4 of these infants also had plus disease, 4 of these 146 
infants received laser treatment and one received intravitreal bevacizumab), grade ≥4 (n=0). No infant 147 
developed retinal detachment (Stage 4 or worse) during the study. 148 
Those infants who did not develop ROP had higher initial haemoglobin levels (on admission) than 149 
infants who did develop ROP (p=0.009), as shown in Table 2 and there was weak evidence that they 150 
have a lower initial %HbF (83.3% vs. 92.3%, p=0.06). Infants who developed ROP had significantly 151 
lower (p=0.0001) mean %HbF during their admission compared to those infants who did not develop 152 
ROP (Table 2).  153 
Table 2 154 
 155 
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When plotting HbF% from each full blood count against corrected gestational age there appears to be 156 
two populations. Those infants who developed ROP have noticeably lower HbF% when compared to 157 
those infants without ROP (Figure 1). 158 
Figure 1 159 
 160 
The ordinal regression model produced similar results to the univariate associations above (Table 161 
3).There was only weak evidence that initial HbF% was associated with increasing risk of ROP grade 162 
(p=0.070) and this association disappeared after adjusting for birthweight, gestation at birth and 163 
volume of transfusion (p=0.261). In contrast there was strong evidence for an association between 164 
Mean %HbF and increasing risk of ROP grade in both the unadjusted (p<0.001) and the adjusted 165 
analyses (p=0.034). 166 
Table 3 167 
 168 
 169 
 170 
 171 
 172 
 173 
Discussion 174 
Whilst very preterm infants who developed ROP had similar initial %HbF when compared to those 175 
who did not develop ROP, we observed that as hypothesized, mean %HbF was significantly lower in 176 
the ROP group during their inpatient stay than in the babies who did not develop ROP. A lower %HbF 177 
may be a proxy or surrogate marker for sickness, as neonates who are more unwell will be more likely 178 
to require and receive blood transfusions. We therefore included volume of blood transfused as an 179 
approximate proxy marker of illness severity in the logistic regression model and an association still 180 
seemed to hold between lower %HbF and ROP development. There is physiological evidence 181 
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supporting left shift of the oxy-haemoglobin dissociation curve with increasing %HbF. It is therefore 182 
biologically plausible that a lower HbF concentration (and higher HbA concentration) provides greater 183 
oxygen delivery to the developing retina. Evidence of this effect (ROP) has been found in our study. It 184 
may therefore be that maintaining higher HbF levels for longer confers some protection against ROP 185 
development.  186 
We recognise limitations with our study, notably a small sample size. Identifying causal factors in ROP 187 
development is not possible in this small cohort study due to the large number of variables and 188 
confounding factors over this time period as well as a relatively heterogeneous patient population. 189 
We considered supplemental oxygen therapy to be part of the causal pathway leading to ROP 190 
development, rather than as a confounder and did not therefore adjust for it in these models.  In a 191 
larger study, it would be useful to explore in more detail the relationship between supplemental 192 
oxygen, intercurrent illness and blood transfusions on %HbF and on the development of ROP. There 193 
is a need for further research to establish evidence for a potential causal relationship between HbF% 194 
and ROP risk. 195 
Various interventions including laser therapy and angiogenesis inhibitors are utilised to manage 196 
established ROP and much research is ongoing in this area. However, if high risk infants can be 197 
recognised and there is a possibility of enhancing intrinsic protective factors, then ROP development 198 
could potentially be minimised or prevented. Delayed cord clamping has been shown to deliver 199 
additional blood to the newborn from the placental bed.18, 19 This could potentially reduce or delay 200 
the need for subsequent transfusion, in turn facilitating maintenance of HbF. There is already 201 
reluctance to transfuse liberally in preterm neonates due to NEC risk, exposure to donors and risk of 202 
transfusion reaction, but risk of ROP development might also need to be considered if further research 203 
supports the hypothesis that early loss of HbF predisposes an infant to developing ROP. 204 
 205 
Conclusions 206 
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To our knowledge this is the first study to investigate and find an association between HbF 207 
concentration, blood transfusion and ROP development.   It is possible that HbF is a protective factor 208 
against ROP and that transfusion of adult (HbA) blood may play a part in ROP development by suddenly 209 
making more oxygen available to the developing retina and downregulating VEGF, resulting in arrest 210 
of the advancing front of retinal vasculature. Subsequent reduction of oxygen supply leads to 211 
ischaemia of the unvascularised peripheral retina and marked upregulation of VEGF with the 212 
development of fundoscopic signs of ROP. Larger studies are required to investigate these associations 213 
further. 214 
 215 
Summary 216 
What was known before 217 
• Retinopathy of prematurity (ROP) is a major cause of morbidity in the preterm population 218 
• Oxygen is known to be the predominant causal factor in ROP development 219 
• ROP has been shown to be associated with blood transfusion 220 
What this study adds 221 
• Blood transfusion dramatically reduces the fetal haemoglobin (HbF) concentration 222 
• Those infants who develop ROP have significantly lower mean fetal haemoglobin (HbF) levels 223 
Maintaining higher HbF levels may be protective against ROP 224 
Acknowledgements 225 
Sharon Evans, Lead Biomedical Scientist for Special Haematology, Blood Sciences, North Bristol Trust 226 
Southmead Hospital- analysis of all blood samples using HPLC. 227 
Kirsty Stevenson, Laboratory technician, The Unit for the Support of Trials and Research, Dpt. of 228 
Clinical Biochemistry, Bristol Royal Infirmary- identification of enrolled infant blood samples and 229 
forwarding to analysis laboratory. 230 
 231 
Competing interests: None 232 
 233 
Funding: David Telling Charitable Trust grant 234 
 235 
10 
 
Contributors 236 
C Stutchfield: Contributed to study design. Recruited patients, designed data extraction proforma and 237 
extracted all case note and laboratory data. Assisted with data analysis. Drafted scientific paper. 238 
A Jain: Contributed to study design. Recruited patients, assisted with data analysis, edited scientific 239 
paper. 240 
D Odd: Contributed to study design. Recruited patients, statistical analysis, edited scientific paper. 241 
C Williams: Contributed to study design, performed all ROP screening, assisted with data analysis, 242 
edited scientific paper. 243 
R Markham: Principal Investigator. Study inception and design. Secured charitable funding and edited 244 
scientific paper. 245 
 246 
 247 
 248 
 249 
 250 
 251 
 252 
 253 
 254 
References  255 
1. Campbell K. Intensive oxygen therapy as a possible cause of retrolental fibroplasias; a clinical 256 
approach. Med J Aust 1951;2(2):48-50. 257 
2. Askie LM, Brocklehurst P, Darlow BA, Finer N, Schmidt B, Tarnow-Mordi W, et al. NeOProM 258 
Collaborative Group. NeOProM: Neonatal oxygenation prospective meta-analysis collaboration study 259 
protocol. BMC Pediatr 2011,11:6. 260 
3. BOOST II United Kingdom Collaborative Group, BOOST II Australia Collaborative Group, BOOST II 261 
New Zealand Collaborative Group. Stenson BJ, Tarnow-Mordi WO, Darlow BA, Simes J, Juszczak E, 262 
Askie L, et al . Oxygen saturation and outcomes in preterm infants. N Engl J Med 2013;368(22):2094-263 
2104. 264 
4. SUPPORT study group. Carlo WA, Finer NN, Walsh MC, Rich W, Gantz MG, Laptook MR, et al. 265 
Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010;362(21):1959-266 
1969. 267 
11 
 
5. Fortes Filho JB, Eckert GU, Procianoy L, Barros CK, Procianoy RS. Incidence and risk factors for 268 
retinopathy of prematurity in very low and extremely low birth weight infants in a unit-based 269 
approach in Southern Brazil. Eye (Lond) 2009;23(1):25-30. 270 
6. Dani C, Reali MF, Bertini G, Martelli E, Pezzati M, Rubaltelli FF. The role of blood transfusions and 271 
iron intake on retinopathy of prematurity. Early Hum Dev 2001;62(1):57-63. 272 
7. Hellstrom A, Hard AL, Engstrom E, Niklasson A, Andersson E, Smith L, Lofqvist C. Early weight gain 273 
predicts retinopathy in preterm infants: new, simple, efficient approach to screening. Pediatrics 274 
2009;123(4):e638-645. 275 
8. Hesse L, Eberl W, Schlud M, Poets CF. Blood transfusion, iron load and retinopathy of prematurity. 276 
Eur J Pediatr 1997;156(6):465-470. 277 
9. Cooke RW, Clark D, Hickey-Dwyer M, Weindling AM. The apparent role of blood transfusions in 278 
the development of retinopathy of prematurity. Eur J Paediatr 1993;152(10):833-836. 279 
10. Englert JA, Saunders RA, Purohit D, Hulsey TC, Ebeling M. The effect of anaemia on retinopathy 280 
of prematurity in extremely low birth weight infants. J Perinatol 2001;21(1):21-26. 281 
11. Terrenato L, Bertilaccio C, Spinelli P, Colombo B. The switch from haemoglobin F to A: The time 282 
course of qualitative and quantitative variations of haemoglobin after birth. Br J Haematol 283 
1981;47(1):31-41. 284 
12. Bard H. The postnatal decline of hemoglobin F synthesis in normal full term infants. J Clin Invest 285 
1975;55(2):395-398. 286 
13. Guyton AC. Regulation of cardiac output. Anesthesiology 1968;29:314-326. 287 
14. Oski FA.  The erythrocyte and its disorders. In: Nathan A & Oski FA. Haematology of Infancy and 288 
Childhood. WB Saunders, Philadelphia 1993:18-43. 289 
15. De Halleux V, Truttmann A, Gagnon , Bard H. The effect of blood transfusion on the hemoglobin 290 
oxygen dissociation curve of very early preterm infants during the first week of life. Semin Perinatol 291 
2002;26(6):411-415. 292 
16. UK Retinopathy of prematurity guideline 2008 (accessed January 2016): 293 
http://www.rcpch.ac.uk/system/files/protected/page/ROP%20Guideline%20-%20Jul08%20final.pdf 294 
17. The International Classification of Retinopathy of Prematurity revisited. International Committee 295 
for the Classification of Retinopathy of Prematurity. Arch Ophthalmol 2005;123(7):991-999.  296 
18. Elimian A, Goodman J, Escobedo M, Nightingale L, Knudtson E, Williams M. Immediate compared 297 
with delayed cord clamping in the preterm neonate: a randomised controlled trial. Obstet and 298 
Gynecol 2014;124(6):1075-1079. 299 
19. McDonald SJ, Middleton P, Dowswell T, Morris PS. Cochrane in Context: Effect of timing of 300 
umbilical cord clamping in term infants on maternal and neonatal outcomes. Evid Based Child Health 301 
2014;9(2):398-400. 302 
 303 
12 
 
 304 
 305 
 306 
 307 
 308 
 309 
 310 
 311 
 312 
 313 
 314 
 315 
 316 
 317 
 318 
 319 
 320 
Tables 321 
Table 1: Demographic and ROP* outcome data  322 
Variable No ROP ROP P 
Male 9 (40.9%) 5 (35.7%) 0.441 
Non-white ethnicity 2 (9.1%) 0 (0%) 0.411 
Multiple birth 11 (50.0%) 1 (7.1%) 0.027 
RBCᶧ transfusions 0 (0-1) 3 (1-5) <0.001 
Total RBC transfusion (ml/kg) 0 (0-20) 53 (20-103) <0.001 
Culture positive sepsis  2 (9.1%) 3 (21.4%) 0.297 
Gestation (weeks) 29.2 (1.1) 26.6 (1.6) <0.001 
Birth weight (grams) 1160 (261) 924 (205) 0.007 
Days on ventilator 1 (0-2) 6 (2-20) <0.001 
Days on CPAP 10 (6-27) 30 (14-39) 0.028 
Days on supplementary O2 28 (7-51) 50 (21-73) 0.051 
    
Values are mean (SD), median (IQR) or n(%) as appropriate. *Retinopathy of Prematurity; ᶧ Red blood 323 
cell  324 
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 325 
 326 
 327 
Table 2: Comparison of haematological values between those infants who developed ROP and those 328 
that did not 329 
 No ROP (95% CI) (n=22) ROP (95% CI) (n=14) p value 
Initial Hb (g/L) 162.5 (153.2, 171.8)  143.6 (133.3, 153.9) 0.009 
Mean Hb (g/L) 134.9 (116.0, 153.7) 112.4 (102.8, 122.1) 0.06 
Initial %HbF 92.3    (89.9, 94.7) 83.3    (71.1, 95.5) 0.06 
Mean %HbF 91.87  (87.2, 96.5) 61.75  (44.5, 79.0) 0.0001 
 330 
 331 
 332 
Table 3: Association between haematological values and ROP 333 
Variable OR (95% CI)  Adjusted* OR (95% CI)  
Initial HbF% 0.96 (0.93-1.00) 0.97 (0.91-1.03) 
Mean HbF% 0.94 (0.90-0.97) 0.94 (0.90-0.99) 
* Adjusted for birthweight, gestation and total transfusion volume. OR= odds ratio. CI= confidence interval. 334 
